About us

HOLTRA was founded with the vision to improve particle analysis by reporting much more than size and concentration. We recognized that differentiation of particle types based on optical properties could dramatically improve the understanding of nanoparticle preparations across a range of industries.

We have realized this vision with our DAISY-NTA instrument, setting the future standard for particle analysis by providing unprecedented information about submicron- and nanoparticles.

We provide advanced instruments as well as expert analytical services. By providing scientists with better data, we make research and development work more effective. In growing medical fields such as advanced therapy medicinal products (ATMP), which rely heavily on nano-scale engineered particles, our contribution across research, development, and manufacturing will help to improve patient safety and health.

Our team:

Fredrik Eklund, CEO

Paul Manna, Application lead

Nicolas Weiss, Product Developer

Edvin Johansson, Software developer

Daniel Midtvedt, Assistant professor, Gothenburg University (Advisor, Co-founder)

Erik Olsén, Postdoc, Gothenburg University / University of British Columbia (Advisor, Co-founder)

Technology

Learn more about the advantages of our instrument and the technology underpinning it

Analysis Service

If you have need for high quality analysis or would like to test our technology with your own samples you can read more here

Request a Demo

See for yourself how our instrument provides unprecedented insight into your nanoparticle samples